Related Experiment Videos

[Short duration of initial intravenous treatment in 70 pediatric patients with osteoarticular infections]

M Alejandra Prado S1, Macarena Lizama C, Anamaría Peña D

  • 1Unidad de Infectología, Servicio de Pediatría, Hospital Dr. Sótero Del Río, Santiago, Chile.

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|February 15, 2008
PubMed

Insights

Seven days of initial intravenous antibiotics for pediatric osteoarticular infections (OAI) proved effective. This shorter IV course, followed by oral treatment, showed no short-term complications in most children.

Area of Science:

  • Pediatric infectious diseases
  • Antibiotic stewardship in pediatrics
  • Osteoarticular infections (OAI) management

Context:

  • Osteoarticular infections (OAI) are uncommon in children.
  • There is ongoing debate regarding the necessity of extended intravenous antimicrobial therapy for pediatric OAI.

Purpose:

  • To evaluate the efficacy and complication rate of a 7-day intravenous antibiotic regimen followed by oral treatment for pediatric OAI.
  • To characterize the clinical presentation, evolution, and outcomes of children with OAI.

Summary:

  • A study of 70 children with OAI found that 7 days of initial intravenous antibiotics followed by 4-6 weeks of oral therapy was effective.
  • The majority of patients, including those requiring extended IV treatment, showed no short-term complications.
  • Staphylococcus aureus was the predominant pathogen, often affecting the lower extremities.

Impact:

  • This study suggests that a 7-day intravenous antibiotic course is a viable and effective initial treatment strategy for pediatric osteoarticular infections.
  • Findings support shorter intravenous antibiotic durations, potentially improving patient care and reducing healthcare costs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...